Search

Your search keyword '"Finetti, Pascal"' showing total 934 results

Search Constraints

Start Over You searched for: Author "Finetti, Pascal" Remove constraint Author: "Finetti, Pascal"
934 results on '"Finetti, Pascal"'

Search Results

2. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network

3. Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression

4. Mutational landscape of inflammatory breast cancer

7. Axin1 Protects Colon Carcinogenesis by an Immune-Mediated Effect

8. CXCL1/CXCR2 and CCL5/CCR1/CCR5 Promote Radiation-Induced Reprogramming of Breast Non-cancer Stem Cells into Cancer Stem Cells and Predict Patient Clinical Outcome

10. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

12. Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

13. BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells

17. Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

18. The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

26. An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity

27. Supplementary Data from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate

28. Supplementary Tables 1-7 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

29. Data from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

31. Supplementary Table from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate

32. Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate

33. Supplementary Figures 1-4 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

36. Supplementary Tables S1-S5 from Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers

37. Supplementary Table 2 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

38. Supplementary Tables from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

39. Supplementary Tables from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

40. Supplementary Data File and Legend from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

41. Supplementary Table 1 from Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)

42. Supplementary Table 3 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

43. Supporting Information from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

44. Supplementary Figure 7 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

45. Supplementary Figure S1 from Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers

46. Supplementary Materials and Methods from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

47. Supplementary Figures from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

48. Supplementary Figure 1 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

49. Supplementary Figure 5 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

50. Supplementary Figure 3 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

Catalog

Books, media, physical & digital resources